Menu
01/06/2015
Scientists Discover Radiotherapy Improvements For Cancers
Scientists from Cancer Research UK have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness across a wide range of cancers, according to a study published in the Journal of Clinical Investigation.
Tumours often grow so quickly that some of the cells do not have access to the body’s blood supply, causing them to become oxygen-starved. This rapid growth usually sends signals to the cells to die, but in cancers with faults in a gene called p53, present in at least half of all cancers, this signal is blocked meaning the cells carry on growing.
The researchers found that six genes that help protect the body against cancer were less active in oxygen-starved cancer cells when p53 was also faulty.
In the absence of two of these genes, PHLDA3 and INPP5D, a gene called AKT becomes permanently switched on preventing the cells from dying despite being oxygen-starved.
When drugs designed to block AKT were given to mice with tumours and lab-grown cancer cells lacking p53, the radiotherapy killed more tumour cells.
(CD)
Tumours often grow so quickly that some of the cells do not have access to the body’s blood supply, causing them to become oxygen-starved. This rapid growth usually sends signals to the cells to die, but in cancers with faults in a gene called p53, present in at least half of all cancers, this signal is blocked meaning the cells carry on growing.
The researchers found that six genes that help protect the body against cancer were less active in oxygen-starved cancer cells when p53 was also faulty.
In the absence of two of these genes, PHLDA3 and INPP5D, a gene called AKT becomes permanently switched on preventing the cells from dying despite being oxygen-starved.
When drugs designed to block AKT were given to mice with tumours and lab-grown cancer cells lacking p53, the radiotherapy killed more tumour cells.
(CD)
Related UK National News Stories
Click here for the latest headlines.
23 June 2003
Scientists identify gene that can 'stop' ovarian cancer
Cancer Research UK scientists have claimed to have isolated a gene that has the power to stop ovarian cancer developing, according to a report published yesterday. Researchers found that the gene, known as OPCML, was "switched off" in almost 90% of the ovarian tumours that were tested.
Scientists identify gene that can 'stop' ovarian cancer
Cancer Research UK scientists have claimed to have isolated a gene that has the power to stop ovarian cancer developing, according to a report published yesterday. Researchers found that the gene, known as OPCML, was "switched off" in almost 90% of the ovarian tumours that were tested.
27 June 2014
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
20 February 2004
Charity hails potential breakthrough to cancer treatment
Stripping cancer cells of their defences against chemotherapy with a new class of anti-resistance drug has the potential to improve treatment for many solid tumours, Cancer Research UK scientists have said.
Charity hails potential breakthrough to cancer treatment
Stripping cancer cells of their defences against chemotherapy with a new class of anti-resistance drug has the potential to improve treatment for many solid tumours, Cancer Research UK scientists have said.
04 November 2003
'Golden nano-shells' could target inoperable tumours
Microscopic 'golden nano-shells' could be used to target inoperable tumours in humans, according to a US research team. The minute silica particles, which are coated with a thin layer of gold, heat up when exposed to near-infrared light and offer a means to kill cancer cells without harming surrounding healthy tissue.
'Golden nano-shells' could target inoperable tumours
Microscopic 'golden nano-shells' could be used to target inoperable tumours in humans, according to a US research team. The minute silica particles, which are coated with a thin layer of gold, heat up when exposed to near-infrared light and offer a means to kill cancer cells without harming surrounding healthy tissue.
-
Northern Ireland WeatherThis Evening and Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Perhaps a touch of ground frost. Cloud will spread east towards morning. Minimum temperature 2 °C.
